Category: IBS
Complementary and Alternative Medicine for the Management of Irritable Bowel Syndrome
G&H What are the most commonly used complementary and alternative medicine therapies among patients with irritable bowel syndrome? LN A number of survey studies have […]
The Emerging Role of Brain-Gut Therapies for Irritable Bowel Syndrome
G&H What is behavioral therapy, and why would it be helpful for patients with irritable bowel syndrome? MR Behavioral therapy, when applied in a gastroenterology […]
The Emerging Role of Mast Cells in Irritable Bowel Syndrome
G&H What factors contribute to the pathogenesis of irritable bowel syndrome? GB The diagnosis of irritable bowel syndrome (IBS) is based on symptom criteria, and […]
The Role of Gut-Brain Interactions in Influencing Symptoms of Irritable Bowel Syndrome
G&H What is the evidence to support a role of the microbiome in the pathogenesis of irritable bowel syndrome? EM Four recent studies have demonstrated […]
Improving the Treatment of Irritable Bowel Syndrome With the Rome IV Multidimensional Clinical Profile
G&H How do the Rome IV criteria differ from the Rome III criteria? DD One of the biggest changes with the Rome IV criteria is […]
Medical Therapies in the Pipeline for Irritable Bowel Syndrome
G&H Which medical therapies are currently available to treat irritable bowel syndrome? MC Most of the currently available treatment options for irritable bowel syndrome (IBS) […]
The Effect of Digital Health Technology on Patient Care and Research
G&H What is the current state of digital health? CA Compared to the advances in technology outside of health care, digital health has lagged behind […]
Updates to the Rome Criteria for Irritable Bowel Syndrome
G&H What are the Rome IV criteria, and how were they developed? LC The Rome criteria were originally developed to understand functional gastrointestinal disorders (FGIDs), […]
Controversies and Recent Developments of the Low-FODMAP Diet
Abstract: The low–fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) diet is a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible short-chain […]
Update on Irritable Bowel Syndrome Diagnostics and Therapeutics
Gastroenterology & Hepatology Volume 12, Issue 7, July 2016 Mark Pimentel, MD Associate Professor, Medicine Director, GI Motility Program Director, GI Motility Laboratory Cedars-Sinai Medical Center […]